Advertisement

ASO Author Reflections: Impact of Operative Technique on Anastomotic Failure During Cytoreductive Surgery for Peritoneal Malignancies—Surgeon Preference is Fine

  • Jason T. Wiseman
  • Jordan M. CloydEmail author
ASO Author Reflections
  • 14 Downloads

Notes

Disclosures

The authors report no conflicts of interest.

References

  1. 1.
    Chouliaras K, Levine EA, Fino N, Shen P, Votanopoulos KI. Prognostic factors and significance of gastrointestinal leak after cytoreductive surgery (CRS) with heated intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2017;24(4):890–7.CrossRefGoogle Scholar
  2. 2.
    McDermott FD, Heeney A, Kelly ME, Steele RJ, Carlson GL, Winter DC. Systematic review of preoperative, intraoperative and postoperative risk factors for colorectal anastomotic leaks. Br J Surg. 2015;102(5):462–79.CrossRefGoogle Scholar
  3. 3.
    Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253(5):890–9.CrossRefGoogle Scholar
  4. 4.
    Wiseman JT, Kimbrough C, Beal EW, et al. Predictors of anastomotic failure following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: does technique matter? Ann Surg Oncol. 2019.  https://doi.org/10.1245/s10434-019-07964-x.CrossRefPubMedGoogle Scholar
  5. 5.
    Jaehne J. Cytoreductive procedures—strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks. J Surg Oncol. 2009;100(4):302–5.CrossRefGoogle Scholar
  6. 6.
    Desantis M, Bernard JL, Casanova V, et al. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbeck’s Arch Surg. 2015;400(1):37–48.CrossRefGoogle Scholar
  7. 7.
    Dodson RM, Kuncewitch M, Votanopoulos KI, Shen P, Levine EA. Techniques for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25(8):2152–8.CrossRefGoogle Scholar
  8. 8.
    Canda AE, Sokmen S, Terzi C, et al. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20(4):1082–7.CrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of SurgeryThe Ohio State UniversityColumbusUSA

Personalised recommendations